UnitedHealth Group announced higher than expected earnings this week, celebrating an 18 percent year-over-year increase to $185 billion in 2106 revenue. But not everyone’s cheering.
The names of biologic and biosimilar medicines will include randomly generated four-letter suffixes, the Food and Drug Administration announced Thursday. The agency’s final guidance followed
News on Tuesday that President-elect Donald Trump may form a federal panel on vaccine safety prompted outcry from physicians and advocates. Word of the panel
About 83 percent of Americans say they could depend upon their health insurer if diagnosed with a serious illness like cancer, according to Aimed Alliance
New York Governor Andrew Cuomo has signed into law a bill that protects patients from step therapy, marking a victory for advocates in the state.
New polling data from The Boston Globe reveals that U.S. physicians are prescribing fewer opioids. But how does the trend impact patients – and the
Two American public health epidemics are colliding – creating new headaches for policymakers and more heartache for communities across the country. As the opioid abuse
By Brian Kennedy, Executive Director, Global Alliance for Patient Access A new position paper from the European Crohn’s and Colitis Organisation has garnered attention from physicians and patient advocates